STOCK TITAN

SI-BONE to Truist Securities MedTech Conference on June 17, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
SI-BONE (NASDAQ: SIBN), a medical device company focused on sacropelvic disorders, has announced its participation in the 2025 Truist Securities MedTech Conference in Boston. The company's management will conduct a fireside chat on June 17, 2025, at 10:00 a.m. PT/1:00 p.m. ET. Investors can access the live webcast by registering through a provided link or visiting the company's website's "Investors" section. The webcast recording will remain available for replay for at least 90 days following the event.
SI-BONE (NASDAQ: SIBN), un'azienda di dispositivi medici specializzata nei disturbi sacropelvici, ha annunciato la sua partecipazione alla Truist Securities MedTech Conference 2025 a Boston. Il management dell'azienda terrà una chiacchierata informale il 17 giugno 2025 alle 10:00 PT/13:00 ET. Gli investitori potranno seguire la diretta streaming registrandosi tramite un link fornito o visitando la sezione "Investitori" del sito web aziendale. La registrazione della trasmissione sarà disponibile in replica per almeno 90 giorni dopo l'evento.
SI-BONE (NASDAQ: SIBN), una empresa de dispositivos médicos enfocada en trastornos sacropélvicos, ha anunciado su participación en la Conferencia MedTech 2025 de Truist Securities en Boston. La dirección de la compañía realizará una charla informal el 17 de junio de 2025 a las 10:00 a.m. PT/1:00 p.m. ET. Los inversores pueden acceder a la transmisión en vivo registrándose mediante un enlace proporcionado o visitando la sección "Inversores" en el sitio web de la empresa. La grabación de la transmisión estará disponible para reproducción durante al menos 90 días después del evento.
SI-BONE(NASDAQ: SIBN)는 천골골반 장애에 중점을 둔 의료기기 회사로, 2025년 보스턴에서 열리는 Truist Securities MedTech 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 6월 17일 오전 10시(태평양 표준시)/오후 1시(동부 표준시)에 비공식 대화를 진행할 예정입니다. 투자자들은 제공된 링크를 통해 등록하거나 회사 웹사이트의 "투자자" 섹션을 방문하여 라이브 웹캐스트에 접속할 수 있습니다. 웹캐스트 녹화는 행사 후 최소 90일 동안 재생할 수 있습니다.
SI-BONE (NASDAQ : SIBN), une entreprise de dispositifs médicaux spécialisée dans les troubles sacropelviens, a annoncé sa participation à la conférence MedTech 2025 de Truist Securities à Boston. La direction de la société animera une discussion informelle le 17 juin 2025 à 10h00 PT/13h00 ET. Les investisseurs peuvent accéder à la diffusion en direct en s'inscrivant via un lien fourni ou en visitant la section « Investisseurs » du site web de l'entreprise. L'enregistrement de la diffusion restera disponible en replay pendant au moins 90 jours après l'événement.
SI-BONE (NASDAQ: SIBN), ein auf sakropelvine Erkrankungen spezialisiertes Medizintechnikunternehmen, hat seine Teilnahme an der Truist Securities MedTech Konferenz 2025 in Boston angekündigt. Die Geschäftsleitung des Unternehmens wird am 17. Juni 2025 um 10:00 Uhr PT/13:00 Uhr ET ein informelles Gespräch führen. Investoren können den Live-Webcast verfolgen, indem sie sich über einen bereitgestellten Link registrieren oder die Rubrik "Investoren" auf der Unternehmenswebsite besuchen. Die Aufzeichnung des Webcasts wird mindestens 90 Tage nach der Veranstaltung zum Nachsehen verfügbar sein.
Positive
  • None.
Negative
  • None.

SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, June 17, 2025, at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by registering at this link: Truist Securities MedTech Conference. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse Implant System®, SI-BONE has supported over 4,500 physicians in performing a total of over 120,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies with over 160 peer reviewed publications including two randomized controlled trials. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation and pelvic trauma.

For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.

SI-BONE, Sacropelvic Solutions, iFuse Implant System®, iFuse Bedrock Granite, and iFuse TORQ, are registered trademarks, and iFuse 3D, iFuse TORQ TNT, and iFuse INTRA are trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved. 

Investor Contact: Saqib Iqbal, investors@si-bone.com


FAQ

When is SI-BONE (SIBN) presenting at the Truist Securities MedTech Conference 2025?

SI-BONE will be presenting on Tuesday, June 17, 2025, at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time.

How can investors access SI-BONE's (SIBN) presentation at the Truist MedTech Conference?

Investors can access the presentation by registering through the provided link or by visiting the 'Investors' section of SI-BONE's website at www.si-bone.com.

How long will SI-BONE's (SIBN) Truist Conference presentation be available for replay?

The webcast will be archived and available for replay for at least 90 days after the event.

What type of presentation will SI-BONE (SIBN) give at the Truist Securities Conference?

SI-BONE's management will be hosting a fireside chat presentation format at the conference.
Si-Bone

NASDAQ:SIBN

SIBN Rankings

SIBN Latest News

SIBN Stock Data

787.94M
37.91M
3.09%
95.51%
2.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA